Event Announcements

Stem cells: from basic research to bioprocessing : Not too late to submit a poster

The Deadline for abstract submissions for oral presentation is March 10th 2015
 Abstracts for poster presentation only can be submitted up to two weeks before the event
This event has an open abstract session.  Abstracts can be submitted on any subject related to Stem Cells
You can download the instructions for authors at
09 June 2015 – 11 June 2015
This event will highlight and discuss recent advances in strategies for controlling stem cell fate and reprogramming (including new insights into the molecular basis of pluripotency and differentiation) together with the progress towards therapeutics and bioprocessing.
Talks include:Chemical reprogramming of human somatic cells. 
Dr Pascale V Guillot, BSc MSc PhD,Senior Lecturer in Maternal and Fetal Medicine, ifWH, UCL,Head of the Cellular Reprogramming and Perinatal Therapy Group, ifWH, UCL,Honorary Senior Lecturer, Imperial College LondonMicroRNA Activity and Adult Stem Cell Differentiation: Utilising the Epigenome
Assistant Professor Christopher J. Payne, PhD, Human Molecular Genetics Program, Ann & Robert H. Lurie Children’s Hospital of Chicago Research Center, Departments of Pediatrics and Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
Molecular toxicity of nanoparticles using mouse bone marrow mesenchymal stem cells
Dr. PV. Mohanan, PhD, FST, FASc(Aw), FSAB, Scientist & Head, Toxicology Division, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Poojapura, Thiruvananthapuram, Kerala, IndiaDirect Conversion of Pluripotent Human Embryonic Stem Cells into Functional Human Neuronal or Cardiomyocyte Cell Therapy Derivatives for Regenerative Medicine
Dr. Xuejun H Parsons, San Diego Regenerative Medicine Institute & Xcelthera Inc, San Diego, CA, United States

Synthetic mRNAs as optimised tools for stem cell generation and for manipulating cellular phenotypes
Dr. Guido Krupp, CEO and President, AmpTec GmbH, Koenigstr. 4A D-22767 Hamburg, Germany

Decellularized organs: Whole organ construction with stem cells
Dr Karthikeyan Narayanan, Senior Research Scientist, Institute of Bioengineering and Nanotechnology, NANOS, Biopolis, Singapore

The identification of novel factors involved in migration of stem cells to  site of injury
Dr Adiba Isa, Postdoc, Dr.Med.Sci., Laboratory of Molecular Endocrinology (KMEB), Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark

Pluripotent stem cell models to understand human heart disease
Dr Gabor Foldes MD PhD, National Heart and Lung Institute, Imperial College London, Imperial Centre for Experimental and Translational Medicine, Hammersmith Campus, London, UK

Human stem cells as tools to model neural damage and cell death pathways
Dr Patrizia Ferretti, Stem Cells and Regenerative Medicine Section, UCL Institute of Child Health, London, UK

Cell therapy bioprocesses to support organ transplants
Dr Marianne Ellis, RAEng/The Leverhulme Trust Senior Research Fellow, Senior Lecturer, Department of Chemical Engineering, University of Bath, Bath, UK

Dr Kirsten McEwen, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London, UK

3D-in vitro models – where are we and where do we go from here
Dr Arno Gutleb,PhD, ERT, Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, Luxembourg

Latest Euroscicon Tweets